Sagimet Biosciences Inc (SGMT) PT Raised to $28 at Oppenheimer
Oppenheimer analyst Jay Olson raised the price target on Sagimet Biosciences Inc (NASDAQ: SGMT) to $28.00 (from $25.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
